In this review, we examine alkaloids from natural origin as inhibitors of the NRF2 pathway and as activators of tumor-suppressive properties to provide valuable information for the future development of alkaloid-based NRF2 inhibitors as a new therapeutic approach for the disruption of NRF2 oncogenic functions. Here, NFE2L2 is linked to neoplasm.